News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Pfizer arthritis drug wins approval, to challenge Humira

Started by riky, November 07, 2012, 11:44:22 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

Pfizer arthritis drug wins approval, to challenge Humira

<p><a href="http://news.yahoo.com/pfizer-arthritis-drug-wins-approval-challenge-humira-092706936--finance.html"><img src="http://l.yimg.com/bt/api/res/1.2/5j7Eag6BnRYD7V_P9PcWVg--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2012-11-07T093017Z_1_CBRE8A60QEJ00_RTROPTP_2_PHARMACEUTICALS.JPG" width="130" height="86" alt="People walk past the Pfizer World headquarters in New York" align="left" title="People walk past the Pfizer World headquarters in New York" border="0" /></a>(Reuters) - U.S. regulators on Tuesday approved Pfizer Inc's Xeljanz treatment for rheumatoid arthritis, one of the company's most potentially lucrative experimental drugs, which is now poised to compete with Abbott Laboratories Inc's top-selling Humira. The U.S. Food and Drug Administration said it had approved Pfizer's pill for patients with moderate to severe rheumatoid arthritis who have not benefited from or been able to tolerate the standard oral treatment, methotrexate. Xeljanz can be used by itself or in combination with methotrexate and certain other standard treatments. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login